Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 5/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.34 |
| ▸ | HPGD | P15428 | 3/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TYMP | P19971 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | CASP7 | P55210 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.32 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11988006 | 0.90 | ALDH1A1 (0.35) | CYP1A2CYP2A6ALDH1A1HPGDHSD17B10 | |
| SCHEMBL12964671 | 0.83 | KDM4E (0.31) | CYP1A2CYP2A6ATML3MBTL1KDM4E | |
| SCHEMBL13425164 | 0.81 | CYP1A2 (0.41) | CYP1A2CYP2A6ALDH1A1HPGDHSD17B10 | |
| SCHEMBL12936999 | 0.81 | KDM4E (0.31) | ATMKDM4E | |
| SCHEMBL12570267 | 0.80 | SMN1; SMN2 (0.43) | CYP1A2ALDH1A1HPGDHSD17B10TSHR | |
| SCHEMBL14144361 | 0.80 | CYP1A2 (0.40) | CYP1A2CYP2A6ALDH1A1HPGDHSD17B10 | |
| SCHEMBL26634699 | 0.77 | CYP1A2 (0.47) | CYP1A2CYP2A6ALDH1A1HPGDHSD17B10 | |
| SCHEMBL11954814 | 0.73 | CYP1A2 (0.42) | CYP1A2CYP2A6ALDH1A1HPGDHSD17B10 | |
| SCHEMBL13359275 | 0.72 | MAOA (0.37) | CYP1A2ALDH1A1HPGDHSD17B10KMT2A | |
| SCHEMBL3215683 | 0.72 | KDM4E (0.37) | CYP1A2CYP2A6ALDH1A1HPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2227454-B1 | PROCESS FOR THE PREPARATION OF AN ENANTIOMERIC TRISUBSTITUTED 3,4-DIHYDRO-ISOQUINOLINE DERIVATIVE | ACTELION PHARMACEUTICALS LTD (CH) | 2015-09-30 | — | — | EP | disclosed |
| EP-2227455-B1 | TRISUBSTITUTED 3,4-DIHYDRO-1H-ISOQUINOLIN COMPOUND, PROCESS FOR ITS PREPARATION, AND ITS USE | ACTELION PHARMACEUTICALS LTD (CH) | 2011-10-12 | — | — | EP | disclosed |
| US-7863443-B2 | Phosphoramidite ligand and production method of allylic amine using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-01-04 | — | — | US | disclosed |
| US-7863443-B2 | Phosphoramidite ligand and production method of allylic amine using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-01-04 | — | — | US | disclosed |
| US-20100240849-A1 | Method for Polymerizing Cyclic Olefin Having Polar Functional Group, Olefin Polymer Produced Thereby, Optical Anisotropic Film Comprising the Same, and Catalyst Composition for Polymerizing the Cyclic Olefin | LG CHEM, LTD. (KR) | 2010-09-23 | — | — | US | disclosed |
| EP-2213638-A1 | Method for the asymmetric hydrogenation of olefins utilising photoisomerisation | DSM IP Assets B.V. (NL) | 2010-08-04 | — | — | EP | disclosed |
| US-20100069684-A1 | ASSYMMETRIC HYDROGENERATION OF PROCHIRAL COMPOUNDS | DSM IP ASSETS B.V. (NL) | 2010-03-18 | — | — | US | disclosed |
| US-20100069684-A1 | ASSYMMETRIC HYDROGENERATION OF PROCHIRAL COMPOUNDS | DSM IP ASSETS B.V. (NL) | 2010-03-18 | — | — | US | disclosed |
| WO-2009083899-A2 | PROCESS FOR THE PREPARATION OF AN ENANTIOMERIC TRISUBSTITUTED 3,4-DIHYDRO-ISOQUINOLINE DERIVATIVE | ACTELION PHARMACEUTICALS LTD (CH) | 2009-07-09 | — | — | WO | disclosed |
| WO-2009083903-A1 | TRISUBSTITUTED 3,4-DIHYDRO-1H-ISOQUINOLIN COMPOUND, PROCESS FOR ITS PREPARATION, AND ITS USE | ACTELION PHARMACEUTICALS LTD (CH) | 2009-07-09 | — | — | WO | disclosed |
| US-20090054689-A1 | PHOSPHORAMIDITE LIGAND AND PRODUCTION METHOD OF ALLYLIC AMINE USING THE SAME | Carreira, Erick M. (CH) | 2009-02-26 | — | — | US | disclosed |
| US-20090054689-A1 | PHOSPHORAMIDITE LIGAND AND PRODUCTION METHOD OF ALLYLIC AMINE USING THE SAME | Carreira, Erick M. (CH) | 2009-02-26 | — | — | US | disclosed |
| WO-2007145478-A1 | METHOD FOR POLYMERIZING CYCLIC OLEFIN HAVING POLAR FUNCTIONAL GROUP, OLEFIN POLYMER PRODUCED THEREBY, OPTICAL ANTISOTROPIC FILM COMPRISING THE SAME, AND CATALYST COMPOSITION FOR POLYMERIZING THE CYCLIC OLEFIN | LG CHEM, LTD. (KR) | 2007-12-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090054689-A1 | PHOSPHORAMIDITE LIGAND AND PRODUCTION METHOD OF ALLYLIC AMINE USING THE SAME | ADH5, SELENOI, ADH1A | CYP1A2 1817/4885CYP2A6 1458/4885ALDH1A1 29/4885 |
| US-20100069684-A1 | ASSYMMETRIC HYDROGENERATION OF PROCHIRAL COMPOUNDS | PDHB, ME1, PDHA1 | CYP1A2 689/4885CYP2A6 1661/4885ALDH1A1 102/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.